<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Genetics</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Genetics</journal-title><trans-title-group xml:lang="ru"><trans-title>Генетика</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0016-6758</issn><issn publication-format="electronic">3034-5103</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">686170</article-id><article-id pub-id-type="doi">10.31857/S0016675825010092</article-id><article-id pub-id-type="edn">VEFHND</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>ГЕНЕТИКА ЧЕЛОВЕКА</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Alu polymorphisms of autophagy and apoptosis regulatory genes as human lifespan factors</article-title><trans-title-group xml:lang="ru"><trans-title>Alu-полиморфизм генов-регуляторов аутофагии и апоптоза как фактор продолжительности жизни человека</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Erdman</surname><given-names>V. V.</given-names></name><name xml:lang="ru"><surname>Эрдман</surname><given-names>В. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>danivera@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Karimov</surname><given-names>D. D.</given-names></name><name xml:lang="ru"><surname>Каримов</surname><given-names>Д. Д.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>danivera@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tuktarova</surname><given-names>I. А.</given-names></name><name xml:lang="ru"><surname>Туктарова</surname><given-names>И. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>danivera@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Petintseva</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Петинцева</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>danivera@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Timasheva</surname><given-names>Y. R.</given-names></name><name xml:lang="ru"><surname>Тимашева</surname><given-names>Я. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>danivera@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nasibullin</surname><given-names>T. R.</given-names></name><name xml:lang="ru"><surname>Насибуллин</surname><given-names>Т. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>danivera@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Biochemistry and Genetics – Subdivision of the Ufa Federal Research Centre of the Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Институт биохимии и генетики – обособленное структурное подразделение Уфимского федерального исследовательского центра Российской академии наук</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Bashkir State Medical University</institution></aff><aff><institution xml:lang="ru">Башкирский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Ufa Research Institute of Occupational Medicine and Human Ecology</institution></aff><aff><institution xml:lang="ru">Уфимский научно-исследовательский институт медицины труда и экологии человека</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2025</year></pub-date><volume>61</volume><issue>1</issue><fpage>91</fpage><lpage>102</lpage><history><date date-type="received" iso-8601-date="2025-06-27"><day>27</day><month>06</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Russian Academy of Sciences</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Российская академия наук</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Russian Academy of Sciences</copyright-holder><copyright-holder xml:lang="ru">Российская академия наук</copyright-holder></permissions><self-uri xlink:href="https://transsyst.ru/0016-6758/article/view/686170">https://transsyst.ru/0016-6758/article/view/686170</self-uri><abstract xml:lang="en"><p>To assess the contribution to survival of Alu-insertions in the <italic>ACE, PLAT, COL13A1, LAMA2, CDH4, SEMA6A, PKHD1L1, STK38L, HECW1, TEAD1</italic> genes, which are candidates of aging and longevity, amid the senile physiological and pathological phenotype, was carried out the association analysis with life expectancy. Survival and mortality data were obtained for 1,382 elderly people, who were selected from the sample of Tatars residing in the Republic of Bashkortostan (total 1790 people from 18 to 109 years). Mortality risk was higher among carriers of the <italic>STK38L</italic> Alu-insertion genotype (Ya5ac2145*<italic>II</italic>, <italic>HR</italic> = 2.07, <italic>P</italic> = 0.02). Alu-insertion in the <italic>HECW1</italic> and <italic>TEAD1</italic> genes has demonstrated a survival protection effect (Ya5NBC182*<italic>II</italic>, <italic>HR </italic>= 0.71, <italic>P</italic> = 0.038 and Ya5ac2013*<italic>II</italic>, <italic>HR</italic> = 0.74, <italic>P</italic> = 0.035 respectively). The survival amid the persons with various clinical phenotypes was associated with the Alu polymorphism of the <italic>SEMA6A</italic> (Yb8NBC597*<italic>ID</italic>, <italic>HR</italic> = 0.54, <italic>P</italic> = 0.016 for the cerebrovascular diseases), <italic>TEAD1</italic> (Ya5ac2013*<italic>II</italic>, <italic>HR</italic> = 0.57, <italic>P</italic> = 0.016 for the cardiovascular pathologies) and <italic>LAMA2</italic> (Ya5-MLS19*<italic>ID</italic>, <italic>HR</italic> = 0.36, <italic>P</italic> = 0.03 for multimorbidity status) genes. Thus, the genes involved in the regulation of autophagy and apoptosis were associated with survival and longevity.</p></abstract><trans-abstract xml:lang="ru"><p>Для оценки вклада Alu-инсерций в генах-кандидатах старения и долголетия <italic>ACE,</italic> <italic>PLAT</italic>, <italic>COL13A1,</italic> <italic>LAMA2</italic>, <italic>CDH4,</italic> <italic>SEMA6A</italic>, <italic>PKHD1L1</italic>, <italic>STK38L</italic>, <italic>HECW1</italic>, <italic>TEAD1 </italic>в выживаемость на фоне старческого физиологического и патологического фенотипа проведен анализ ассоциаций с продолжительностью жизни. Получены данные о причинах смерти 1382 человек преклонного возраста из выборки татар, проживающих в Республике Башкортостан (всего 1790 человек от 18 до 109 лет). Риск смерти оказался повышен у лиц с Alu-инсерцией в гене <italic>STK38L </italic>(Ya5ac2145*<italic>II</italic>, <italic>HR</italic> = 2.07, <italic>P</italic> = 0.022). Alu-инсерционные варианты генов <italic>HECW1</italic> и <italic>TEAD1</italic> продемонстрировали протективный в отношении выживаемости эффект (Ya5NBC182*<italic>II</italic>, <italic>HR</italic> = 0.71, <italic>P </italic>= 0.038 и Ya5ac2013*<italic>II</italic>, <italic>HR</italic> = 0.74, <italic>P</italic> = 0.035 соответственно). С выживаемостью при различных клинических фенотипах ассоциированы Alu-полиморфные варианты генов <italic>SEMA6A </italic>(Yb8NBC597*<italic>ID</italic>, <italic>HR</italic> = 0.54, <italic>P</italic> = 0.016 при цереброваскулярных заболеваниях), <italic>TEAD1 </italic>(Ya5ac2013*<italic>II</italic>, <italic>HR</italic> = 0.57, <italic>P</italic> = 0.016 при сердечно-сосудистых патологиях) и <italic>LAMA2</italic> (Ya5-MLS19*<italic>ID</italic>, <italic>HR</italic> = 0.36, <italic>P</italic> = 0.03 при полиморбидности). Таким образом, с выживаемостью и достижением долголетия оказались ассоциированы гены, вовлеченные в регуляцию аутофагии и апоптоза.</p></trans-abstract><kwd-group xml:lang="en"><kwd>aging</kwd><kwd>longevity</kwd><kwd>Alu-polymorphism</kwd><kwd>TEAD1</kwd><kwd>HECW1</kwd><kwd>STK38L</kwd><kwd>LAMA2</kwd><kwd>SEMA6A genes</kwd><kwd>survival analysis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>старение</kwd><kwd>долголетие</kwd><kwd>Alu-полиморфизм</kwd><kwd>гены TEAD1</kwd><kwd>HECW1</kwd><kwd>STK38L</kwd><kwd>LAMA2</kwd><kwd>SEMA6A</kwd><kwd>анализ выживаемости</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Российский научный фонд</institution></institution-wrap><institution-wrap><institution xml:lang="en">The Russian Science Foundation</institution></institution-wrap></funding-source><award-id>24-25-00179</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Мушкамбаров Н.Н. Геронтология in polemico. Монография. М.: “Мед. информ. агентство”, 2011. 464 с.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Чупаха М.В., Белоусова О.Н., Сухатерина Е.В. Характеристика биологического возраста и данных антропометрии при артериальной гипертензии на фоне метаболического синдрома у пациентов среднего и пожилого возраста // Соврем. проблемы здравоохранения и мед. статистики. 2024. № 1. С. 335–347. https://doi.org/10.24412/2312-2935-2024-1-335-347</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Maier H., Jeune B., Vaupel J.W. Exceptional Lifespans. Springer Nature, 2021. 344 p.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Le Breton A., Bettencourt M.P., Gendrel A.V. Navigating the brain and aging: Exploring the impact of transposable elements from health to disease // Front. Cell. Dev. Biol. 2024. V. 12. https://doi.org/10.3389/fcell.2024.1357576</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Maxwell P.H. What might retrotransposons teach us about aging? // Curr. Genet. 2016. V. 62. P. 277–282. https://doi.org/10.1007/s00294-015-0538-2</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Li M., Schifanella L., Larsen P.A. Alu retrotransposons and COVID-19 susceptibility and morbidity // Hum. Genomics. 2021. V. 15. P. 2–11. https://doi.org/10.1186/s40246-020-00299-9</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Эрдман В.В., Каримов Д.Д., Насибуллин Т.Р. и др. Роль Alu-полиморфизма генов PLAT, PKHD1L1, STK38L и TEAD1 в формировании признака долгожительства // Успехи геронтологии. 2016. Т. 29. № 5. С. 709–716.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Каримов Д.Д., Эрдман В.В., Насибуллин Т.Р. и др. Alu-инсерционно-делеционный полиморфизм генов COL13A1 и LAMA2: анализ ассоциаций с долгожительством // Генетика. 2016. Т. 52. №. 10. С. 1185–1193. https://doi.org/10.7868/S0016675816100039</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Erdman V.V., Karimov D.D., Tuktarova I.A. et al. Alu deletions in LAMA2 and CDH4 genes are key components of polygenic predictors of longevity // Intern. J. of Mol. Sci. 2023. № 21. https://doi.org/10.3390/ijms232113492</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Wang D., He J., Huang B. et al. Emerging role of the Hippo pathway in autophagy // Cell Death &amp; Disease. 2020. V. 11. № 10. P. 880. https://doi.org/10.1038/s41419-020-03069-6</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Zhou Y.H., Huang T.T., Cheng A.S.L. et al. The TEAD family and its oncogenic role in promoting tumorigenesis // Intern. J. Mol. Sci. 2016. V. 17. № 1. P. 138. https://doi.org/10.3390/ijms17010138</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Reed M.J., Damodarasamy M., Banks W.A. The extracellular matrix of the blood-brain barrier: Structural and functional roles in health, aging, and Alzheimer’s disease // Tissue Barriers. 2019. V. 7. № 4. https://doi.org/10.1080/21688370.2019.1651157</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Carmignac V., Svensson M., Körner Z. еt аl. Autophagy is increased in laminin α2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A // Human Mol. Genet. V. 20. № 24. P. 4891–4902. https://doi.org/10.1093/hmg/ddr427</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Fard D., Tamagnone L. Semaphorins in health and disease // Cytokine &amp; Growth Factor Reviews. 2021. V. 57. P. 55–63. https://doi.org/10.1016/j.cytogfr.2020.05.006</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Zhang C., Hong C.D., Wang H.L. et al. The role of semaphorins in small vessels of the eye and brain // Pharmacol. Research. 2020. V. 160. https://doi.org/10.1016/j.phrs.2020.105044</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Kaushik A., Parashar S., Ambasta R.K., Kumar P. Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing pathways in neurodegenerative disorders and cancer // Ageing Res. Reviews. 2024. V. 96. P. 102279. https://doi.org/10.1016/j.arr.2024.102279</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Le D., Brown L., Malik K., Murakami S. Two opposing functions of angiotensin-converting enzyme (ACE) that links hypertension, dementia, and aging // Intern. J. Mol. Sci. 2021. V. 22. № 24. https://doi.org/10.3390/ijms222413178</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Loos R.J.F., Yeo G.S.H. The genetics of obesity: from discovery to biology // Nature Rev. Genet. 2022. V. 23. № 2. P. 120–133. https://doi.org/10.1038/s41576-021-00414-z</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Yepes M. The plasminogen activation system promotes neurorepair in the ischemic brain // Current Drug Targets. 2019. V. 20. № 9. P. 953–959. https://doi.org/10.2174/1389450120666181211144550</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Resink T.J., Joshi M.B., Kyriakakis E. Cadherins and cardiovascular disease // Swiss Med. Weekly. 2009. V. 139. № 0910. P. 122–134.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Cordaux R., Batzer M.A. The impact of retrotransposons on human genome evolution // Nature Rev. Genet. 2009. V. 10. № 10. P. 691–703. https://doi.org/10.1038/nrg2640</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Nefedova L.N., Kim A.I. The role of retroelements in the evolution of animal genomes // Biol. Bul. Reviews. 2022. V. 12. № 1. P. 29–40. https://doi.org/10.1134/S2079086422010042</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Davidson-Pilon C. Lifelines: Survival analysis in Python // J. Open Source Software. 2019. V. 4. № 40. P. 1317. https://doi.org/10.21105/joss.01317</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Cao L., Li H., Liu X. et al. Expression and regulatory network of E3 ubiquitin ligase NEDD4 family in cancers // BMC Cancer. 2023. V. 23. № 1. P. 526. https://doi.org/10.1186/s12885-023-11007-w</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Li Y., Zhang L., Zhou J. et al. Nedd4 E3 ubiquitin ligase promotes cell proliferation and autophagy // Cell Proliferation. 2015. V. 48. № 3. P. 338–347. https://doi.org/10.1111/cpr.12184</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Li Y., Ozaki T., Kikuchi H. et al. A novel HECT-type E3 ubiquitin protein ligase NEDL1 enhances the p53-mediated apoptotic cell death in its catalytic activity-independent manner // Oncogene. 2008. V. 27. № 26. P. 3700–3709. https://doi.org/10.1038/sj.onc.1211032</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Quiroga M., Rodríguez-Alons A., Alfonsín G. et al. Protein degradation by E3 ubiquitin ligases in cancer stem cells // Cancers. 2022. V. 14. https://doi.org/10.3390/cancers14040990</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Huang S.S., Hsu L.J., Chang N.S. Functional role of WW domain-containing proteins in tumor biology and diseases: Insight into the role in ubiquitin-proteasome system // FASEB Bioadv. 2020. V. 2. P. 234–253. https://doi.org/10.1096/fba.2019-00060</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Гомбоева Д.Е., Брагина Е.Ю., Назаренко М.С., Пузырев В.П. Обратная коморбидность между онкологическими заболеваниями и болезнью Гентингтона: обзор эпидемиологических и биологических доказательств // Генетика. 2020. Т. 56. № 3. С. 260–271. https://doi.org/10.31857/S0016675820030054</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Piccolo S., Dupont S., Cordenonsi M. The biology of YAP/TAZ: Hippo signaling and beyond // Physiol. Reviews. 2014. V. 94. № 4. P. 1287–1312. https://doi.org/10.1152/physrev.00005.2014</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Ramaccini D., Pedriali G., Perrone M. et al. Some insights into the regulation of cardiac physiology and pathology by the Hippo pathway // Biomedicines. 2022. V. 10. № 3. P. 726. https://doi.org/10.3390/biomedicines10030726</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Lin K.C., Park H.W., Guan K.L. Regulation of the Hippo pathway transcription factor TEAD // Trends Biochem. Sci. 2017. V. 42. P. 862–872. https://doi.org/10.1016/j.tibs.2017.09.003</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Zhang Y., Ren Y., Li X. et al. A review on decoding the roles of YAP/TAZ signaling pathway in cardiovascular diseases: Bridging molecular mechanisms to therapeutic insights // Intern. J. Biol. Macromolecules. 2024. https://doi.org/10.1016/j.ijbiomac.2024.132473</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Hergovich A. The roles of NDR protein kinases in Hippo signalling // Genes. 2016. V. 7. № 5. P. 21. https://doi.org/10.3390/genes7050021</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Sharif A.A.D., Hergovich A. The NDR/LATS protein kinases in immunology and cancer biology // Seminars in Cancer Biology. 2018. V. 48. P. 104–114.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Jonischkies K., Del Angel M., Demiray Y.E. et al. The NDR family of kinases: Essential regulators of aging // Frontiers in Mol. Neurosci. 2024. V. 17. https://doi.org/10.3389/fnmol.2024.1371086</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Rawat P., Thakur S., Dogra S. et al. Diet-induced induction of hepatic serine/threonine kinase STK38 triggers proinflammation and hepatic lipid accumulation // J. Biol. Chemistry. 2023. V. 299. № 5. https://doi.org/10.1016/j.jbc.2023.104678</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Aman Y., Schmauck-Medina T., Hansen M. et al. Autophagy in healthy aging and disease // Nat. Aging. 2021. V. 1. № 8. P. 634–650. https://doi.org/10.1038/s43587-021-00098-4</mixed-citation></ref></ref-list></back></article>
